Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Myoma × Radiofrequency Ablation × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Hepatocellular 12 Cholangiocarcinoma 7 Liver Neoplasms 5 Barrett Esophagus 5 Thyroid Neoplasms 4 Recurrence 4 Lung Neoplasms 4 Thyroid Nodule 3 Pancreatic Neoplasms 3 Neoplasm Metastasis 3 Esophageal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Breast Neoplasms 3 Thyroid Diseases 2 Thyroid Cancer, Papillary 2 Pain 2 Neoplasms 2 Hyperaldosteronism 2 Colonic Neoplasms 2 Carcinoma, Renal Cell 2 Squamous Intraepithelial Lesions 1 Prostatic Neoplasms 1 Papillary Thyroid Microcarcinoma 1 Pancreatic cancer, adult 1 Pancreatic Neuroendocrine Tumors, WHO Grade I-II 1 Neoplasm Micrometastasis 1 Myoma 1 Multi-organ Metastatic Colorectal Cancer 1 Menorrhagia 1 Lymphatic Metastasis 1

Interventions

Uterine Myomectomy 3 Uterine Artery Embolization 2 Sodium Chloride 2 testo 1 Terlipressin 1 Saline Solution 1 Radiofrequency Ablation 1 Magnesium Sulfate 1 Hysteroscopy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02163525 2025-09-30

Post Market TRUST - U.S.A. Study

Acessa Health, Inc.

Phase NA Completed

Leiomyoma, Menorrhagia, Myoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡